Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HiHa study
NL-OMON58644Phase 4Not yet recruiting
- Sponsor
- Reinier Haga Orthopedisch Centrum
- Start
- Mar 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of ropivacaine and epinephrine, sponsored by Reinier Haga Orthopedisch Centrum. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
ropivacaineepinephrine
Beyond the preview
Go deeper on NL-OMON58644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON58644.